Research indicated that cells from recurrent solid tumors demonstrated increased expression of ATF3, implying its role in promoting ovarian cancer aggressiveness, treatment resistance, and recurrence (Bopple et al., 2024). The gene discussed is ATF3; the disease is ovarian carcinoma.